Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03446365 · ClinicalTrials.gov registry record · NA
Peer-Administered Asthma Self-Management Intervention in Urban Middle Schools
A NA study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 243
- Enrollment target
NCT03446365 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 243 participants.
The verdict
NCT03446365, a NA study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 243 participants
- Enrollment target
Study Summary
Health disparities in pediatric asthma persist, with Latino children demonstrating increased asthma morbidity. Middle school children with asthma have greater morbidity than children from any other age group and spend a majority of their day in school, where they must manage any asthma. The investigators developed and piloted a novel group-based intervention - ASMAS (Asthma Self-MAnagement in Schools) in two geographic areas with a high prevalence of urban and Latino children with asthma: Providence, Rhode Island, and San Juan, Puerto Rico. ASMAS is a 4-session, peer-facilitated asthma self-management intervention specific to the school setting for Latino middle school (6th-8th graders) children. It is delivered by trained High School Juniors and Seniors of Latino descent with asthma. The preliminary effects of ASMAS for improving asthma outcomes and self-management relative to controls were demonstrated in a previous intervention development study. This study will evaluate ASMAS through a large-scaled Randomized Control Trial with urban middle school students who have persistent asthma in Providence, Rhode Island and San Juan, Puerto Rico and will identify barriers and facilitators to the implementation of ASMAS. These results will inform future, large-scale dissemination in other urban school settings.
Interventions
- BEHAVIORAL ASMAS
- BEHAVIORAL Asthma education plus child health
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 243 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03446365
The ClinicalTrials.gov registry entry for NCT03446365 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 243 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ASMAS is the first listed.
NCT03446365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03446365 about?
NCT03446365 is a clinical study titled "Peer-Administered Asthma Self-Management Intervention in Urban Middle Schools". Health disparities in pediatric asthma persist, with Latino children demonstrating increased asthma morbidity. Middle school children with asthma have greater morbidity than children from any other age group and spend a majority of their day in school, where they must manage any asthma. The investig...
What is the current status of trial NCT03446365?
This trial is currently completed. It is a NA study. The enrollment target is 243 participants. The study started on 2019-04-01. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT03446365?
The interventions under investigation include: ASMAS (BEHAVIORAL), Asthma education plus child health (BEHAVIORAL).
Who is sponsoring clinical trial NCT03446365?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.